Dr. Lachance’s interests include not only hematopoietic stem cell transplantation and cell therapy but also the improvement and management of post-transplant complications; the pathophysiology, prevention and treatment of graft-versus-host disease (GVHD); the understanding of the graft-versus-tumour effect; and treatments for hematologic malignancies.